{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:24:31Z","timestamp":1761503071751,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1016\/j.yebeh.2007.09.001","type":"journal-article","created":{"date-parts":[[2007,11,27]],"date-time":"2007-11-27T09:59:56Z","timestamp":1196157596000},"page":"253-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Topiramate in children and adolescents with epilepsy and mental retardation: A prospective study on behavior and cognitive effects"],"prefix":"10.1016","volume":"12","author":[{"given":"Giangennaro","family":"Coppola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Verrotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Resicato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Ferrarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianfranca","family":"Auricchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca Felicia","family":"Operto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Pascotto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2007.09.001_bib1","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1001\/archneur.62.11.1705","article-title":"Topiramate in patients with juvenile myoclonic epilepsy","volume":"62","author":"Biton","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.yebeh.2007.09.001_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0920-1211(00)00202-3","article-title":"Topiramate in refractory partial-onset seizures in children, adolescents and young adults: a multicentric open trial","volume":"43","author":"Coppola","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2007.09.001_bib3","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0920-1211(02)00103-1","article-title":"Topiramate as add-on drug in children, adolescents and young adults with Lennox\u2013Gastaut sindrome: an Italian multicentric study","volume":"51","author":"Coppola","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2007.09.001_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0920-1211(02)00010-4","article-title":"Topiramate as add-on drug in severe myoclonic epilepsy in infancy: an Italian multicenter open trial","volume":"49","author":"Coppola","year":"2002","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2007.09.001_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1017\/S0317167100000366","article-title":"Topiramate in intractable childhood onset epilepsy: a cautionary note","volume":"26","author":"Dooley","year":"1999","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.yebeh.2007.09.001_bib6","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1212\/WNL.52.7.1338","article-title":"A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children","volume":"52","author":"Elterman","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2007.09.001_bib7","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/j.1528-1157.1998.tb01331.x","article-title":"A pilot study of topiramate in the treatment of infantile spasms","volume":"39","author":"Glauser","year":"1998","journal-title":"Epilepsia"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2007.09.001_bib8","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1111\/j.1528-1157.2000.tb02179.x","article-title":"Topiramate in Lennox\u2013Gastaut syndrome: open-label treatment of patients completing a randomized controlled trial","volume":"41","author":"Glauser","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2007.09.001_bib9","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1177\/08830738050200110601","article-title":"Efficacy and safety of topiramate in refractory epilepsy of childhood: long-term follow-up study","volume":"20","author":"Grosso","year":"2005","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2007.09.001_bib10","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1517\/14656566.7.6.811","article-title":"Topiramate and its clinical applications in epilepsy","volume":"7","author":"Guerrini","year":"2005","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.yebeh.2007.09.001_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1053\/seiz.2000.0387","article-title":"Efficacy and tolerability of topiramate in childhood and adolescent epilepsy: a clinical experience","volume":"9","author":"Mohamed","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2007.09.001_bib12","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1053\/seiz.2000.0466","article-title":"Topiramate in the treatment of severe myoclonic epilepsy in infancy","volume":"9","author":"Nieto-Barrera","year":"2000","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2007.09.001_bib13","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S1090-3798(99)90097-1","article-title":"Clinical experience with topiramate in children with intractable epilepsy","volume":"3","author":"Uldall","year":"1999","journal-title":"Eur J Paediatr Neurol"},{"issue":"Suppl. 1","key":"10.1016\/j.yebeh.2007.09.001_bib14","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1177\/0883073800015001S03","article-title":"Use of topiramate in childhood generalized seizure disorders","volume":"15","author":"Wheless","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2007.09.001_bib15","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1177\/0883073800015001S06","article-title":"Pharmacokinetics and pharmacodynamics of topiramate","volume":"15","author":"Bourgeois","year":"2000","journal-title":"J Child Neurol"},{"key":"10.1016\/j.yebeh.2007.09.001_bib16","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1111\/j.1528-1157.2000.tb02173.x","article-title":"Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate","volume":"41","author":"Zhang","year":"2000","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2007.09.001_bib17","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1212\/WNL.43.1_Part_1.41","article-title":"Withdrawal of antiepileptic medications: effects on cognitive function in children\u2014the results of the multicentre \u201cHolmfrid\u201d study","volume":"43","author":"Aldenkamp","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2007.09.001_bib18","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1053\/seiz.1998.0212","article-title":"Topiramate for intractable childhood epilepsy","volume":"8","author":"Moreland","year":"1999","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2007.09.001_bib19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0887-8994(99)00151-4","article-title":"Factors associated with behavioural and cognitive abnormalities in children receiving topiramate","volume":"22","author":"Gerber","year":"2000","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2007.09.001_bib20","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/j.1528-1157.1998.tb01292.x","article-title":"Antiepileptic drug-related cognitive complaints in seizure-free children with epilepsy before and after drug discontinuation","volume":"39","author":"Aldenkamp","year":"1998","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505007003071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505007003071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:20:29Z","timestamp":1761502829000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505007003071"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["S1525505007003071"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2007.09.001","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2008,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topiramate in children and adolescents with epilepsy and mental retardation: A prospective study on behavior and cognitive effects","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2007.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}